Delivery Order SPE2DB24D8003-SPE2DB25FJTKM

Award Date 12/9/24
Potential Completion Date 12/10/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTKM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the prescription medication Concerta ER 36 mg tablets. The contract has a firm fixed price of $2,660.92 and a performance period that ends on December 10, 2024. There is no set-aside designation for this unrestricted contract award.

Dakota Drug, Inc. is a key strategic supplier for the DLA's Troop Support Medical division, holding a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This delivery order contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which enables the efficient delivery of critical medical items to various defense healthcare facilities.

Generated 3/10/25, 9:44 AM